The Association of Body Fat Composition with Risk of Breast, Endometrial, Ovarian and Colorectal Cancers Among Normal Weight Participants in the UK Biobank

Overview

Journal Br J Cancer

Specialty Oncology

Date 2021 Mar 16

PMID 33723399

Citations 12

Authors

Rhonda S Arthur

Andrew J Dannenberg

Mimi Kim

Thomas E Rohan

Affiliations

Soon will be listed here.

Abstract

Background: The association between body fat composition and risk of cancer in normal weight individuals (body mass index (BMI) 18.5-24.9 kg/m) is unclear.

Methods: We examined the association of measures of adiposity with risk of incident cancers of the breast (postmenopausal), endometrium, ovary and colon/rectum among 149,928 normal weight individuals (40-70 years) who were enrolled in the UK Biobank cohort between 2006 and 2010.

Results: All of the body fat measures were positively associated with invasive postmenopausal breast cancer risk (hazard ratios (HR) for the uppermost quintile (Q5) versus the lowest quintile (Q1) ranged from 1.32 (95% CI: 1.09-1.60) for waist circumference (WC) to 1.56 (1.28-1.90) for BMI). Trunk fat mass index (HR: 1.72, 95% CI: 1.02-2.89) and WC (HR: 1.65, 95% CI: 1.01-2.70)) were positively associated with risk of endometrial cancer. Among males, trunk fat:trunk fat free mass ratio, trunk fat:leg fat mass ratio and (HR: 1.63, 95% CI: 1.02-2.60; 1.92, 1.20-3.07 and 1.68, 1.05-2.66, respectively) were positively associated with colon cancer risk. None of the body fat measures was associated with risk of ovarian cancer or colorectal cancer in women.

Conclusion: The findings of this study suggest that the current normal weight category based on BMI includes individuals who are at increased risk of some obesity-related cancers.

Citing Articles

The association between the healthy lifestyle index and MRI-derived body composition measurements in the UK Biobank study.

Peila R, Rohan T Sci Rep. 2025; 15(1):1010.

PMID: 39762360 PMC: 11704033. DOI: 10.1038/s41598-024-84406-z.

Normal weight obesity, circulating biomarkers and risk of breast cancer: a prospective cohort study and meta-analysis.

Wang W, Wang X, Jiang Y, Guo Y, Fu P, He W Br J Cancer. 2024; 132(2):203-211.

PMID: 39609539 PMC: 11747320. DOI: 10.1038/s41416-024-02906-1.

Central obesity may account for most of the colorectal cancer risk linked to obesity: evidence from the UK Biobank prospective cohort.

Safizadeh F, Mandic M, Schottker B, Hoffmeister M, Brenner H Int J Obes (Lond). 2024; .

PMID: 39562688 DOI: 10.1038/s41366-024-01680-7.

Unveiling the causal link between metabolic factors and ovarian cancer risk using Mendelian randomization analysis.

Han L, Xu S, Zhou D, Chen R, Ding Y, Zhang M Front Endocrinol (Lausanne). 2024; 15:1401648.

PMID: 38899007 PMC: 11185996. DOI: 10.3389/fendo.2024.1401648.

The relationship between central obesity and risk of breast cancer: a dose-response meta-analysis of 7,989,315 women.

Chen H, Yuan M, Quan X, Chen D, Yang J, Zhang C Front Nutr. 2023; 10:1236393.

PMID: 38024370 PMC: 10665573. DOI: 10.3389/fnut.2023.1236393.

References

Murphy N, Cross A, Abubakar M, Jenab M, Aleksandrova K, Boutron-Ruault M . A Nested Case-Control Study of Metabolically Defined Body Size Phenotypes and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). PLoS Med. 2016; 13(4):e1001988. PMC: 4821615. DOI: 10.1371/journal.pmed.1001988. View

Gavi S, Feiner J, Melendez M, Mynarcik D, Gelato M, McNurlan M . Limb fat to trunk fat ratio in elderly persons is a strong determinant of insulin resistance and adiponectin levels. J Gerontol A Biol Sci Med Sci. 2007; 62(9):997-1001. DOI: 10.1093/gerona/62.9.997. View

Kim H, Giovannucci E . Sex differences in the association of obesity and colorectal cancer risk. Cancer Causes Control. 2016; 28(1):1-4. DOI: 10.1007/s10552-016-0831-5. View

Karastergiou K, Smith S, Greenberg A, Fried S . Sex differences in human adipose tissues - the biology of pear shape. Biol Sex Differ. 2012; 3(1):13. PMC: 3411490. DOI: 10.1186/2042-6410-3-13. View

Staiger H, Tschritter O, Machann J, Thamer C, Fritsche A, Maerker E . Relationship of serum adiponectin and leptin concentrations with body fat distribution in humans. Obes Res. 2003; 11(3):368-72. DOI: 10.1038/oby.2003.48. View

Sun G, French C, Martin G, Younghusband B, Green R, Xie Y . Comparison of multifrequency bioelectrical impedance analysis with dual-energy X-ray absorptiometry for assessment of percentage body fat in a large, healthy population. Am J Clin Nutr. 2005; 81(1):74-8. DOI: 10.1093/ajcn/81.1.74. View

Candido J, Hagemann T . Cancer-related inflammation. J Clin Immunol. 2012; 33 Suppl 1:S79-84. DOI: 10.1007/s10875-012-9847-0. View

Sorosky J . Endometrial cancer. Obstet Gynecol. 2012; 120(2 Pt 1):383-97. DOI: 10.1097/AOG.0b013e3182605bf1. View

Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K . Body Fatness and Cancer--Viewpoint of the IARC Working Group. N Engl J Med. 2016; 375(8):794-8. PMC: 6754861. DOI: 10.1056/NEJMsr1606602. View

10.

Garofalo C, Surmacz E . Leptin and cancer. J Cell Physiol. 2005; 207(1):12-22. DOI: 10.1002/jcp.20472. View

11.

Goodpaster B, Krishnaswami S, Harris T, Katsiaras A, Kritchevsky S, Simonsick E . Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch Intern Med. 2005; 165(7):777-83. DOI: 10.1001/archinte.165.7.777. View

12.

Basraon S, Mele L, Myatt L, Roberts J, Hauth J, Leveno K . Relationship of Early Pregnancy Waist-to-Hip Ratio versus Body Mass Index with Gestational Diabetes Mellitus and Insulin Resistance. Am J Perinatol. 2015; 33(1):114-21. PMC: 5283057. DOI: 10.1055/s-0035-1562928. View

13.

Kettaneh A, Heude B, Romon M, Oppert J, Borys J, Balkau B . High plasma leptin predicts an increase in subcutaneous adiposity in children and adults. Eur J Clin Nutr. 2006; 61(6):719-26. PMC: 2093948. DOI: 10.1038/sj.ejcn.1602579. View

14.

Duska L, Tew W, Moore K . Epithelial ovarian cancer in older women: defining the best management approach. Am Soc Clin Oncol Educ Book. 2015; :e311-21. DOI: 10.14694/EdBook_AM.2015.35.e311. View

15.

Omiyale W, Allen N, Sweetland S . Body size, body composition and endometrial cancer risk among postmenopausal women in UK Biobank. Int J Cancer. 2020; 147(9):2405-2415. DOI: 10.1002/ijc.33023. View

16.

Manolopoulos K, Karpe F, Frayn K . Gluteofemoral body fat as a determinant of metabolic health. Int J Obes (Lond). 2010; 34(6):949-59. DOI: 10.1038/ijo.2009.286. View

17.

. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet. 1999; 350(9084):1047-59. View

18.

Tikkanen E, Gustafsson S, Knowles J, Perez M, Burgess S, Ingelsson E . Body composition and atrial fibrillation: a Mendelian randomization study. Eur Heart J. 2019; 40(16):1277-1282. PMC: 6475522. DOI: 10.1093/eurheartj/ehz003. View

19.

Iyengar N, Arthur R, Manson J, Chlebowski R, Kroenke C, Peterson L . Association of Body Fat and Risk of Breast Cancer in Postmenopausal Women With Normal Body Mass Index: A Secondary Analysis of a Randomized Clinical Trial and Observational Study. JAMA Oncol. 2018; 5(2):155-163. PMC: 6439554. DOI: 10.1001/jamaoncol.2018.5327. View

20.

Borga M, West J, Bell J, Harvey N, Romu T, Heymsfield S . Advanced body composition assessment: from body mass index to body composition profiling. J Investig Med. 2018; 66(5):1-9. PMC: 5992366. DOI: 10.1136/jim-2018-000722. View